America’s Commercial Lunar Economy Just Got Its Most Important Infrastructure Deal Yet

The race to build permanent infrastructure on the Moon has a new and more serious player. Voyager Technologies (NYSE: VOYG), a Denver-based defense technology and space solutions company, announced Tuesday it has signed a definitive agreement to acquire Astrobotic Technology, the Pittsburgh-based commercial lunar logistics and robotics company, for up to approximately $300 million in a combination of cash and stock. The deal is expected to close by early July 2026, subject to customary regulatory approvals.

For a company that has been quietly assembling a full-stack lunar infrastructure portfolio, the Astrobotic acquisition is the piece that makes the entire architecture operational.

What Astrobotic Brings to the Table

Founded in 2007 as a Carnegie Mellon University spinout, Astrobotic has spent nearly two decades building the hardware, software, and operational expertise required to deliver payloads to the lunar surface reliably and repeatably. The company has secured more than $600 million in NASA and Department of Defense contracts and holds the distinction of having launched America’s first commercial lunar lander. Its core product portfolio includes the Peregrine lander for smaller payload missions, the Griffin lander for larger surface delivery operations, and LunaGrid, a solar power distribution system designed to provide sustained electricity on the lunar surface.

That last element matters as much as the landers. A permanent human presence on the Moon requires more than transportation. It requires power infrastructure that can sustain life, operations, and scientific activity across lunar day-night cycles that last approximately two Earth weeks each. LunaGrid is purpose-built for exactly that requirement.

Astrobotic’s Moon Base headquarters in Pittsburgh will become the center of Voyager’s lunar program following close, with the company’s facility in Mojave also continuing operations.

The Full Stack Voyager Is Building

The Astrobotic acquisition does not stand alone. Voyager has been executing a deliberate vertical integration strategy across the lunar infrastructure stack, and this deal slots directly into that roadmap. The combined company will now span lunar mission management, communications and propulsion, surface delivery through Peregrine and Griffin, surface power through LunaGrid, long-duration habitation through its prior strategic investment in Max Space’s expandable habitat architecture, dust mitigation through Voyager’s proprietary clear-dust repellent coating technology, and in-situ resource production.

That is a comprehensive end-to-end lunar capability assembled through targeted acquisitions rather than organic development alone. The strategic efficiency of that approach is notable for a company operating in the small cap space.

The acquisition directly supports NASA’s Artemis program and Administrator Jared Isaacman’s stated commitment to establishing a permanent American presence on the Moon by 2028. Astrobotic’s Griffin Mission One, recently designated NASA’s Moon Base II mission, is proceeding on schedule and will transition fully under Voyager at close.

Why This Deal Matters for Small Cap Space Investors

The commercial lunar economy is not a distant concept. It is a funded, contracted, timeline-driven government priority with hundreds of millions of dollars already flowing to companies like Astrobotic. What has been missing is the kind of vertically integrated commercial operator capable of managing every layer of a sustained lunar presence. Voyager is systematically becoming that operator.

With SpaceX’s June 12 IPO approaching at a targeted $1.75 trillion valuation and the broader space infrastructure sector attracting record institutional attention, consolidation among smaller space technology companies is accelerating. Voyager’s acquisition of Astrobotic is precisely the kind of strategic move that positions a small cap defense and space company for the contracts, partnerships, and government relationships that will define the commercial lunar economy over the next decade.

Power Metallic Mines Inc. (PNPNF) – Advancing Lion Resource Growth and Expanding District Exploration


Tuesday, June 02, 2026

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Recent Drill Results. Power Metallic reported strong drill results from the Lion deposit, including high-grade near-surface copper intercepts, while metallurgical testing demonstrated excellent recoveries from lower-grade material. The results support resource growth potential and enhance confidence ahead of the upcoming NI 43-101 Mineral Resource Estimate (MRE) expected in late July and a Preliminary Economic Assessment (PEA) in December 2026.

Summer Exploration and Drilling Program. Power Metallic has expanded its summer exploration program at the Nisk Project with advanced geophysical surveys and more than 30,000 meters of planned drilling. The program is designed to identify extensions of known mineralization and generate new discovery targets across the company’s Nisk land package while supporting future resource growth.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Summit Midstream Corp (SMC) – Inaugural Stock Repurchase Program


Tuesday, June 02, 2026

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Stock Repurchase Authorization. Summit Midstream Corporation announced that its Board of Directors has authorized the company’s first stock repurchase program, allowing for the repurchase of up to $35 million of outstanding common stock. As of May 8, shares outstanding were 20.3 million, including 13.8 million common shares and 6.5 million Class B common shares.

Terms of the Program. Summit may repurchase shares through open market transactions, privately negotiated purchases, block trades, or other methods permitted under applicable securities laws. Repurchase activity will depend on market conditions, share price, debt covenant compliance, and other factors. The program has no expiration date, does not require the company to buy back any specific number of shares, and may be suspended or terminated at any time.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

MAIA Biotechnology (MAIA) – Phase 3 THIO-104 Trial Design Presented At ASCO


Tuesday, June 02, 2026

Robert LeBoyer, Senior Vice President, Equity Research Analyst, Biotechnology, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Phase 3 THIO-104 Design Is Consistent With Expectations. MAIA presented a poster on May 31, 2026, at the Annual ASCO (American Society of Clinical Oncology) Meeting. The poster detailed the design of its ongoing Phase 3 THIO-104 trial that tests ateganosine (aka THIO) in combination with the checkpoint inhibitor cemiplimab as a third-line treatment for patients with non-small cell lung cancer (NSCLC) who have become resistant to CPI treatment and chemotherapy.

Trial Design Is Consistent With Results From Phase 2 THIO-101 Trial. The patient population, selected dose, and combination regimen with Ateganosine 180mg and cemiplimab (Libtayo, from Regeneron) are the same as those in the Phase 2 THIO-101 study. At last analysis as of June 30, 2025, this regimen showed a median observed Overall Survival (OS) of 17.8 months, compared with published studies reporting an OS of 5.8 months.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

V2X (VVX) – Raising Price Target


Tuesday, June 02, 2026

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Raising Price Target. With VVX share moving north of our $72 price target, we are increasing our target to $92 while maintaining our Outperform rating. At our new price target, VVX shares would trade at 0.8x our projected 2026 revenue, 11x our projected 2026 adjusted EBITDA, and 15.5x our projected 2026 adjusted EPS. These multiples are in line with VVX’s key competitors. VX shares are up approximately 52% y-t-d, versus an 11% rise for the S&P 500.

Overhang Removed. With American Industrial Partners’ May 2026 sale of approximately 2 million VVX shares, the firm is essentially out of V2X shares, completing a two-year process as AIP liquidated its 61%+ ownership stake in V2X acquired in the merger of Vectrus and Vertex, removing an ongoing overhang of stock, in our view. An entity affiliated with Vertex Aerospace did, however, continue to beneficially own 375,420 shares, or approximately 1.2%, of V2X’s outstanding common stock following the most recent share sale.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Greenwich LifeSciences, Inc. (GLSI) – Additional Phase 3 FLAMINGO-01 Data Presented At ASCO Meeting


Tuesday, June 02, 2026

Robert LeBoyer, Senior Vice President, Equity Research Analyst, Biotechnology, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Additional Data Presented At ASCO. Greenwich LifeSciences presented an abstract and poster at the ASCO Annual Meeting.  The data assessed non-HLA-A*02 patients in the open-label arm after six monthly doses of GLA-100. The data show statistically significant injection site reaction (ISR) and immune response at baseline, with increases over time.

Patients Were Evaluated After Initial Immune Stimulation. Patients received the Primary Immunization Series (PIS), consisting of six vaccinations over the first six months of the trial. The fourth, fifth, and sixth vaccinations showed a significant increase in the percentage of patients showing an ISR compared to baseline. Of the 247 patients enrolled, 208 had both baseline vaccination and assessments at 4, 5, or 6 months.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Aurania Resources (AUIAF) – First Tranche of Private Placement Closed


Tuesday, June 02, 2026

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Private Placement Financing. Aurania Resources Ltd. closed the first tranche of its previously announced non-brokered private placement, raising C$678,263.76 through the issuance of 3,768,132 units at C$0.18 per unit. Each unit consists of one common share and one common share purchase warrant. Each warrant entitles the holder to purchase one common share at a price of C$0.35 per share for a period of 24 months following the close of the first tranche. The financing is part of a larger offering of up to 8,333,333 units that could generate total gross proceeds of up to approximately C$1.5 million. Dr. Keith Barron, Aurania’s Chief Executive Officer and President, participated in the financing by acquiring 1,666,666 units.

Use of Proceeds. The net proceeds will be used to fund exploration at the Thor’s Valley epithermal gold project in Iceland, support the Balangero nickel-cobalt tailings retreatment project in Italy, and fund general working capital. In May, Aurania closed its option agreement with St-Georges Eco-Mining Corp (CSE: SX) and its wholly owned subsidiary, Iceland Resources, to work collaboratively to define and execute a phased exploration program at the Thor’s Valley gold project to advance the project toward initial modern resource definition.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Anthropic Just Filed for an IPO at $965 Billion. The AI Capital Cycle Has Entered a New Phase

The artificial intelligence industry’s march toward public markets just crossed a threshold that Wall Street has been watching closely for months. Anthropic, the San Francisco-based AI company behind the Claude family of large language models, confirmed Monday it has submitted a confidential draft S-1 registration statement to the Securities and Exchange Commission — the first formal legal step toward an initial public offering.

The filing contains no share count, no price range, and no confirmed listing date. Under the confidential process, full financial disclosures remain private until the SEC completes its review, at which point Anthropic will decide whether to proceed based on market conditions. A public debut as early as Fall 2026 is widely expected.

What is known is the valuation at which Anthropic is entering this process. Just days before the filing, the company closed a $65 billion Series H funding round co-led by Altimeter Capital, Dragoneer, Greenoaks, Sequoia Capital, Capital Group, Coatue, and D1 Capital Partners, pushing its post-money valuation to approximately $965 billion. That figure places Anthropic ahead of rival OpenAI in private market valuation and positions it at the front of the most consequential IPO pipeline in the history of the technology industry.

The Company Behind the Filing

Anthropic was founded in 2021 by Dario Amodei, Daniela Amodei, and several colleagues who departed OpenAI. The company has built its business on the Claude model family, which spans consumer, enterprise, and frontier AI applications, and has established major compute agreements with Amazon, Google, and Broadcom. Claude is available across AWS, Google Cloud, and Microsoft Azure, giving the company distribution through the three largest cloud platforms simultaneously. The company’s CFO described the latest funding round as support to serve the demand for Claude while expanding research, compute capacity, and product partnerships.

The Broader IPO Context

Anthropic’s filing lands inside what is shaping up to be the most concentrated AI IPO season in market history. Cerebras Systems debuted on Nasdaq in May, surging nearly 90% on its first day of trading in the largest US tech IPO since Uber in 2019. SpaceX’s roadshow begins Thursday with the June 12 Nasdaq listing targeting a $1.75 trillion valuation and a $75 billion raise. OpenAI is expected to follow Anthropic to the SEC with its own filing in the weeks ahead.

The cumulative implied valuation of these four AI companies alone approaches $4 trillion. That number represents an entirely new category of public market listing, and its effect on sentiment, capital allocation, and sector multiples across the AI ecosystem is already being felt.

What It Means for Smaller AI Companies

For investors in the sub-$2 billion AI space, the Anthropic filing matters for a specific reason. Cerebras and Nvidia represent the hardware and infrastructure layer of AI. Anthropic and OpenAI represent the model and software layer. When both layers of the AI stack are simultaneously achieving historic public market valuations, the effect on smaller companies operating across either layer is historically consistent: institutional capital broadens its reach, multiples expand across the sector, and the companies that were already building real products in the space benefit from the rising tide.

The IPO window that cracked open with Cerebras in May is now wide open. Anthropic just made sure of it.

Quantum Computing Inc. Spent $110 Million to Become Vertically Integrated

When Quantum Computing Inc. (Nasdaq: QUBT) announced in December 2025 that it would acquire Luminar Semiconductor for $110 million in cash from a bankrupt parent company, the market’s immediate reaction was a 7% single-day drop. The deal looked expensive, the target was emerging from a Chapter 11 process, and questions about whether a microcap quantum computing company could absorb an acquisition of that scale were entirely legitimate.

Four months later, the first full quarter of post-acquisition results are on the table, and the numbers tell a different story than the initial skepticism suggested.

What QUBT Actually Bought

Luminar Semiconductor was a wholly owned subsidiary of Luminar Technologies, the lidar company that filed for Chapter 11 bankruptcy concurrently with the sale announcement. Critically, Luminar Semiconductor itself was not a debtor in the bankruptcy. It was operating normally as a subsidiary and continued doing so through the court-supervised Section 363 sale process, which QUBT won as the stalking horse bidder. The deal closed February 2, 2026.

What transferred to QUBT was a portfolio of established photonic technology businesses including Black Forest Engineering, Optogration, Freedom Photonics, and EM4 — collectively representing a mature set of capabilities in lasers, photodetectors, optical packaging, and manufacturing. These are not experimental technologies. They have existing commercial customers in defense, sensing, and optical communications, generating real revenue before a single quantum application is layered on top.

The strategic logic was vertical integration. QUBT operates a thin-film lithium niobate foundry in Tempe, Arizona, producing photonic chips that form the hardware foundation for its quantum systems. Luminar Semiconductor’s components are direct building blocks on that technology roadmap. By acquiring the supplier rather than remaining dependent on it, QUBT gained control of its supply chain, expanded its engineering depth, and added an established revenue base in a single transaction.

The Post-Acquisition Numbers

Q1 2026 revenue came in at $3.7 million, surging from near zero in the prior year period and significantly outpacing analyst consensus estimates. The net loss narrowed to $4.1 million, or $0.02 per share, better than expected. Total assets at March 31 stood at approximately $1.6 billion, supported by a cash position of roughly $1.4 billion — a substantial liquidity cushion for a company of this size and stage. The stock gained 7% on earnings day and has advanced nearly 30% over the past month. Six analysts currently carry Buy ratings on the stock with an average price target of $17.83, implying approximately 49% upside from current levels.

The Broader Context

The acquisition does not exist in isolation. Two weeks ago, the Trump administration announced $2 billion in equity investments across nine domestic quantum computing companies under the CHIPS and Science Act framework — a commitment that signals the federal government views quantum computing as a strategic national priority rather than a speculative technology bet. While QUBT was not among the direct recipients in that announcement, the government validation of the sector broadly benefits every company operating in the quantum computing ecosystem.

QUBT’s vertical integration strategy positions it as one of the few quantum companies attempting to control both the photonic hardware and the quantum application stack simultaneously, a differentiated approach in a sector where most competitors rely on third-party component suppliers.

The Risk Profile

The honest assessment includes the other side of the ledger. Earnings are projected to decline significantly on a per-share basis as the company scales operations and absorbs integration costs. The stock trades at extreme price-to-sales multiples relative to current revenue. Cash burn remains a structural feature of the business at this stage, and dilution risk through future capital raises is a real variable. These are not edge cases — they are the central risks any investor in early-stage quantum computing needs to underwrite.

What has changed since the December acquisition announcement is that the revenue baseline is now measurably higher, the integration appears to be proceeding on track, and the government has put $2 billion of validation behind the sector QUBT is building into.

Weatherford Is Acquiring NCS Multistage — and the Timing Says Everything About Where Oil Field Services Is Heading

NCS Multistage is not a generalist oilfield services company. It operates in a specific and technically demanding niche: highly engineered products and support services that optimize well construction, completion, and field development strategies — primarily in horizontal wells drilled in unconventional oil and gas formations. Its technology is designed to improve reliability and production performance across the full well lifecycle, from initial completion design through late-stage production optimization and intervention.

The company operates primarily across North American basins and has established a presence in select international markets including the North Sea, the Middle East, and Argentina. That international footprint, while smaller than Weatherford’s, gives the combined company immediate leverage to cross-sell NCS Multistage’s technology into Weatherford’s six-continent global customer base — which is one of the most compelling near-term value creation levers in the deal.

Why This Deal Makes Sense Right Now

Weatherford is making a direct bet on two intersecting trends. The first is the sustained relevance of unconventional resource development. Despite the ongoing shift toward energy transition narratives, horizontal drilling and hydraulic fracturing in unconventional formations remain the backbone of North American oil and gas production. NCS Multistage’s core technology sits squarely in that production stream, and demand for completion optimization tools that improve per-well economics has not softened.

The second trend is consolidation driven economics. Smaller, specialized oilfield technology companies with strong engineering capabilities but limited distribution reach are increasingly attractive acquisition targets for larger platforms that can scale those technologies globally. NCS Multistage had the technology and the reputation. Weatherford has the footprint and the financial capacity to take it international.

Piper Sandler served as financial advisor to NCS Multistage in the transaction.

The Broader Signal for Small Cap Energy Services

For investors tracking the sub-$2 billion oilfield services and energy technology space, the Weatherford-NCS deal continues a pattern worth monitoring. Specialized completion technology, production optimization tools, and unconventional resource services companies have been consistent acquisition targets as larger players look to deepen technical differentiation rather than compete purely on scale.

The Iran conflict has kept oil prices elevated despite recent ceasefire negotiations, and sustained prices above $90 WTI support the capital spending levels that drive demand for exactly the kind of completion technology NCS Multistage provides. In that environment, companies with defensible technology niches and proven field performance records are not staying independent for long.

SPACtrac Report – BOXABL: Manufacturing The Future Of Housing


Monday, June 01, 2026

Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.

Jacob Mutchler, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Factory-Built housing meets public markets. BOXABL plans to become a publicly traded company through its proposed business combination with FG Merger II Corp. The transaction is expected to provide additional capital to support manufacturing optimization, production scaling, and broader market expansion initiatives. 

Industrializing housing at scale. BOXABL is applying centralized manufacturing processes to residential construction to improve efficiency, lower costs, and accelerate deployment timelines. By standardizing production and reducing transportation complexity, BOXABL aims to deliver lower-cost housing solutions at scale. The company’s modular housing strategy is designed to address growing affordability challenges across entry-level and workforce housing markets. 


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

First Phosphate Corp. (FRSPF) – Private Placement Financing to Fund Exploration and Development


Monday, June 01, 2026

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

LFP Mine-to-Market Supply Chain Integration. First Phosphate Corp. is advancing a vertically integrated North American supply chain for lithium-iron-phosphate (LFP) batteries, with a focus on energy storage, mobility, robotics, data centers, and national security applications. Its flagship Bégin Lamarche project in Québec is a high-purity igneous phosphate deposit that supports the company’s long-term strategy of supplying critical battery materials to the growing LFP battery market.

Private Placement Financing. To accommodate existing investors, First Phosphate announced a non-brokered private placement to raise a minimum of $5 million. The financing will consist of a combination of hard dollar units and flow-through shares priced at C$2.00 each. Hard dollar units will include one common share and one common share purchase warrant exercisable for one common share at a price of C$2.50 per share until December 31, 2026, subject to an accelerated expiry date.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Microcaps Are Beating the S&P 500 by Double in 2026. Most Investors Still Haven’t Noticed

While Wall Street’s attention has been fixed on Nvidia earnings, Fed chair transitions, and Iran ceasefire negotiations, something quieter has been happening at the smaller end of the market. The Russell Microcap Index is up 17.55% year to date. The S&P 500 is up 8.72%. Microcap stocks have more than doubled the return of the 500 largest companies in America through the first five months of 2026, and the story behind that performance is one that most mainstream financial coverage has almost entirely missed.

The Numbers in Full

The 2026 outperformance is not a short-term blip. It is the continuation of a trend that began building in the spring of 2025. Over the past twelve months, the Russell Microcap Index has gained more than 57%, compared to approximately 27% for the S&P 500 over the same period. Microcaps have now outperformed major large cap indices for four consecutive quarters, a streak that Franklin Templeton research confirmed through the end of Q1 2026.

The first quarter told a particularly clear story. Energy was the standout sector within the Russell 2000, delivering a gain of 38.2% — far outpacing every other sector as oil prices surged on the Iran conflict. Small cap value outperformed small cap growth. Higher quality, lower leverage companies outperformed. Dividend-paying names outperformed non-payers. This was not speculative froth driving microcaps higher. It was fundamentals.

Why the Headlines Keep Missing It

The reason this story stays under the radar is structural. The S&P 500 is increasingly a story of extreme concentration. The top ten companies in that index now account for approximately 40% of its total weighting. Last week specifically, just five companies — Nvidia, Micron, Apple, AMD, and Intel — accounted for 75% of the entire index’s weekly gain. When those five companies perform well, the S&P 500 performs well, and every headline reflects that. When they stumble, the index stumbles, even if hundreds of smaller companies are quietly compounding.

That concentration dynamic is precisely what makes the microcap outperformance this year so significant. It is happening despite the noise, not because of it.

The Valuation Story Has Not Closed

Despite the strong performance, microcap and small cap stocks remain historically cheap relative to large caps. The Russell 2000’s weight within the Russell 3000 — a broad measure of how much of total market capitalization small caps represent — sits at 4.6%, compared to a historical average of 7.6%. On a forward price-to-earnings basis, small caps trade at a 30% discount to the S&P 500, a gap that remains near its widest level in over two decades. EV/EBIT valuations for the Russell Microcap Index relative to large caps are near their lowest point in 25 years according to Royce Investment Partners.

Consensus earnings growth estimates for the Russell 2000 are considerably higher than those for the Russell 1000 in 2026. The fundamentals are improving, the valuations remain attractive, and the performance is already reflecting both.

The rotation is not a prediction anymore. It is already underway. The investors who noticed it early are two quarters ahead of the ones still watching the Magnificent Seven.